Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minfeng Liu

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Oncology Research|March 25, 2017
Clinical Value of Capecitabine-Based Combination Adjuvant Chemotherapy in Early Breast Cancer: A Meta-Analysis of Randomized Controlled TrialsGuanling Chen, Zhaoze Guo, Minfeng Liu, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|June 20, 2008
Suppressing effects of down-regulating DNMT1 and DNMT3b expression on the growth of human cholangiocarcinoma cell lineShi Zuo, Jian Luo, Minfeng Liu, et al.
Gland Surgery|November 4, 2021
Preparing PAMAM-<i>NK4</i> nano complexes and examining their <i>in vitro</i> growth suppression effects in breast cancerMinfeng Liu, Zhaoze Guo, Jiangqin Liu, et al.
The Journal of International Medical Research|September 16, 2021
Integrated analyses of long noncoding RNAs and mRNAs in the progression of breast cancerJingyun Guo, Huining Lian, Minfeng Liu, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|March 5, 2015
[Effect of mTOR plasmid transfection on growth of breast cancer MCF-7 cells in vitro]Minfeng Liu, Zhaozhe Guo, Jianyu Dong, et al.
International Journal of Biological Macromolecules|July 27, 2025
Cuproptosis- and m6A-related lncRNA prognostic signature for breast cancer, in which Z68871.1 contributes to triple-negative breast cancer progressionZicheng Zhang, Zhenjian Gao, Qianyu Huang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 8, 2016
Experimental Study of Magnetic Multi-Walled Carbon Nanotube-Doxorubicin Conjugate in a Lymph Node Metastatic Model of Breast CancerJian Ji, Minfeng Liu, Yue Meng, et al.
Molecular Medicine Reports|June 3, 2021
MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple‑negative breast cancer cellsXiaoqi Zeng, Shanshan Jiang, Simin Ruan, et al.
Cancer Management and Research|January 25, 2021
MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR PathwayJingyun Guo, Can Luo, Yuqin Yang, et al.
Journal of Medical Imaging and Radiation Oncology|November 4, 2025
Utility of Quantitative Parameters From Triple-Phase Contrast Enhanced Dual-Energy CT for Predicting Immunohistochemical Biomarkers in Invasive Breast CancerMingwang Chen, Minfeng Liu, Yuting Wu, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Oncology Research|March 25, 2017
Clinical Value of Capecitabine-Based Combination Adjuvant Chemotherapy in Early Breast Cancer: A Meta-Analysis of Randomized Controlled TrialsGuanling Chen, Zhaoze Guo, Minfeng Liu, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|June 20, 2008
Suppressing effects of down-regulating DNMT1 and DNMT3b expression on the growth of human cholangiocarcinoma cell lineShi Zuo, Jian Luo, Minfeng Liu, et al.
Gland Surgery|November 4, 2021
Preparing PAMAM-<i>NK4</i> nano complexes and examining their <i>in vitro</i> growth suppression effects in breast cancerMinfeng Liu, Zhaoze Guo, Jiangqin Liu, et al.
The Journal of International Medical Research|September 16, 2021
Integrated analyses of long noncoding RNAs and mRNAs in the progression of breast cancerJingyun Guo, Huining Lian, Minfeng Liu, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|March 5, 2015
[Effect of mTOR plasmid transfection on growth of breast cancer MCF-7 cells in vitro]Minfeng Liu, Zhaozhe Guo, Jianyu Dong, et al.
International Journal of Biological Macromolecules|July 27, 2025
Cuproptosis- and m6A-related lncRNA prognostic signature for breast cancer, in which Z68871.1 contributes to triple-negative breast cancer progressionZicheng Zhang, Zhenjian Gao, Qianyu Huang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 8, 2016
Experimental Study of Magnetic Multi-Walled Carbon Nanotube-Doxorubicin Conjugate in a Lymph Node Metastatic Model of Breast CancerJian Ji, Minfeng Liu, Yue Meng, et al.
Molecular Medicine Reports|June 3, 2021
MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple‑negative breast cancer cellsXiaoqi Zeng, Shanshan Jiang, Simin Ruan, et al.
Cancer Management and Research|January 25, 2021
MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR PathwayJingyun Guo, Can Luo, Yuqin Yang, et al.
Journal of Medical Imaging and Radiation Oncology|November 4, 2025
Utility of Quantitative Parameters From Triple-Phase Contrast Enhanced Dual-Energy CT for Predicting Immunohistochemical Biomarkers in Invasive Breast CancerMingwang Chen, Minfeng Liu, Yuting Wu, et al.
Pageof 4